Wordt geladen...
Evaluation and Optimization of the Clinical Accuracy of Hybribio's 14 High-Risk HPV with 16/18 Genotyping Assay within the VALGENT-3 Framework
Hybribio’s 14 High-Risk HPV with 16/18 genotyping real-time PCR (HBRT-H14) is a human papillomavirus (HPV) assay with approval from the China Food and Drug Administration that is widely used in China. VALGENT (VALidation of HPV GENotyping Tests) is an established framework for evaluating HPV tests’...
Bewaard in:
| Gepubliceerd in: | J Clin Microbiol |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Microbiology
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7269387/ https://ncbi.nlm.nih.gov/pubmed/32245832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.00234-20 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|